STOCK TITAN
  1. Home
  2. News
  3. ICUI

ICU Medical, Inc. - ICUI STOCK NEWS

Welcome to our dedicated news page for ICU Medical (Ticker: ICUI), a resource for investors and traders seeking the latest updates and insights on ICU Medical.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ICU Medical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ICU Medical's position in the market.

News
ICU Medical to Present at the KeyBanc Life Sciences & MedTech Investor Forum
Rhea-AI Summary
ICU Medical (ICUI) to present at KeyBanc Life Sciences & MedTech Investor Forum on March 20, 2024. Webcast details provided for investors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.4%
Tags
conferences
-
News
ICU Medical to Present at the Raymond James 45ᵗʰ Annual Institutional Investors Conference
Rhea-AI Summary
ICU Medical, Inc. (ICUI) will present at the Raymond James 45th Annual Institutional Investors Conference on March 4, 2024. The presentation will be webcast live and accessible for replay on the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.5%
Tags
conferences
-
News
ICU Medical Announces Fourth Quarter 2023 Results and Provides Fiscal Year 2024 Guidance
Rhea-AI Summary
ICU Medical, Inc. (ICUI) reported fourth-quarter 2023 revenue of $587.9 million, a slight increase from the previous year. However, GAAP gross profit and margin declined. The company saw a net loss of $(17.1) million compared to $(15.5) million in the same period last year. Adjusted diluted earnings per share decreased to $1.57 from $1.60. The CEO mentioned that the results met expectations. Revenue breakdown by product line showed mixed performance. The company provided guidance for Fiscal Year 2024, expecting a GAAP net loss and adjusted EBITDA to be in specific ranges.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.31%
Tags
earnings
News
ICU Medical Announces Time of Fourth Quarter 2023 Earnings Conference Call
Rhea-AI Summary
ICU Medical, Inc. announces the timing of its fourth quarter 2023 earnings release and conference call. The results will be released on February 27th, 2024, followed by a conference call to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.88%
Tags
earnings
-
News
ICU Medical Announces Third Quarter 2023 Results
Rhea-AI Summary
ICU Medical, Inc. announces financial results for Q3 2023. Revenue was $553.3 million, a decrease from $597.9 million in the same period last year. GAAP gross profit was $183.9 million, with a gross margin of 33%. GAAP net income was $7.2 million, compared to a net loss of $(13.2) million in Q3 2022. Adjusted diluted earnings per share were $1.57, down from $1.75 in Q3 2022. Adjusted EBITDA was $89.8 million, a decrease from $92.6 million in Q3 2022.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.31%
Tags
earnings
-
News
ICU Medical Announces Time of Third Quarter 2023 Earnings Conference Call
Rhea-AI Summary
ICU Medical, Inc. announces the time of its third quarter 2023 earnings release and conference call on November 6th, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.11%
Tags
earnings
News
ICU Medical to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference
Rhea-AI Summary
ICU Medical, Inc. to participate in fireside chat at Morgan Stanley Annual Global Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.85%
Tags
conferences
-
News
ICU Medical Announces Second Quarter 2023 Results and Narrows Fiscal Year 2023 Guidance Ranges
Rhea-AI Summary
ICU Medical, Inc. announces financial results for Q2 2023 with revenue of $549.3 million, a decrease from $561.0 million in the same period last year. GAAP gross profit for Q2 2023 was $192.3 million, compared to $167.6 million in Q2 2022. GAAP net loss for Q2 2023 was $(9.9) million, or $(0.41) per diluted share. Adjusted diluted earnings per share for Q2 2023 was $1.88, an increase from $1.37 in Q2 2022. Adjusted EBITDA for Q2 2023 was $98.1 million, compared to $84.7 million in Q2 2022.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.59%
Tags
earnings
-
News
ICU Medical Announces Time of Second Quarter 2023 Earnings Conference Call
Rhea-AI Summary
ICU Medical, Inc. (Nasdaq:ICUI) announces the time of its second quarter 2023 earnings release and conference call, scheduled for August 7th, 2023. The call will be available by phone and webcast, with a replay option. Investors can access the call at (833) 816-1376, conference ID 10180958, or through the company's website at www.icumed.com.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.54%
Tags
earnings
News
ICU Medical Announces First Quarter 2023 Results
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.64%
Tags
earnings
Stock ICUI logo
ICU Medical, Inc.

Nasdaq:ICUI

ICUI Rankings

#1742 Ranked by Market Cap
#4000 Ranked by Stock Gains
N/A Ranked by Dividends

ICUI Stock Data

2.39B
21.01M
12.86%
89.51%
4.07%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
San Clemente

About ICUI

icu medical is in the business of making connections -- human connections. we design and make some of the world's safest, most reliable medical devices and systems for infusion therapy, oncology, and critical care applications. our products improve patient outcomes by helping prevent bloodstream infections and protecting patients and healthcare workers from exposure to infectious diseases or hazardous drugs. our complete product line includes needlefree vascular access devices, custom infusion systems, closed delivery systems for hazardous drugs, advanced sensor catheters and hemodynamic monitoring systems. together, we help forge the human and emotional connections that are a vital link between patients and caregivers, that enhance clinical experience, and are the essence of outstanding quality-of-care. icu medical is headquartered in san clemente, california.